Macrophage-Derived Nucleosides Reduce the Efficacy of Gemcitabine

Cancer Discovery - United States
doi 10.1158/2159-8290.cd-rw2019-032
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors

Unknown

Publisher

American Association for Cancer Research (AACR)

Related search

The MEK1/2 Inhibitor Pimasertib Enhances Gemcitabine Efficacy--Response

Clinical Cancer Research
Cancer ResearchOncology
2016English

The Role of HuR in Gemcitabine Efficacy in Pancreatic Cancer: HuR Up-Regulates the Expression of the Gemcitabine Metabolizing Enzyme Deoxycytidine Kinase

Cancer Research
Cancer ResearchOncology
2009English

A Bone Marrow-Derived Murine Macrophage Model for Evaluating Efficacy of Antimycobacterial Drugs Under Relevant Physiological Conditions.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1994English

Macrophage-Derived Biomarkers of Idiopathic Pulmonary Fibrosis

Pulmonary Medicine
MedicinePulmonaryRespiratory Medicine
2011English

Efficacy of Aromatherapy to Reduce Labor Pain

Archives of Gynecology and Obstetrics
MedicineGynecologyObstetrics
2018English

Efficacy of Warfarin Anticoagulation and Incident Dementia: Does Cognitive Impairment Reduce Efficacy?

Mayo Clinic Proceedings
Medicine
2018English

Macrophage-Derived Lipocalin-2 Transports Iron in the Tumor Microenvironment

OncoImmunology
OncologyAllergyImmunology
2017English

Lipid Homeostasis and the Formation of Macrophage-Derived Foam Cells in Atherosclerosis

Protein & Cell
BiochemistryBiotechnologyDrug DiscoveryCell BiologyMedicine
2012English

Efficacy of Neoadjuvant Gemcitabine and Cisplatin in the Management of Muscle-Invasive Urothelial Carcinoma of the Bladder

Japanese Journal of Urology
Urology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy